Harrow to Participate in B. Riley Securities 23rd Annual Institutional Investor Conference on May 24, 2023

Author's Avatar
May 17, 2023

Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will participate in the upcoming B. Riley Securities 23rd Annual Institutional Investor Conference on Wednesday, May 24, 2023, at the Beverly Hilton Hotel in Beverly Hills, California.